Insider filing · IMNM
Max Rosett
Chief Financial Officer
profile →
Immunome, Inc.
IMNM · Healthcare · 26 filings in 24 months
ticker →
Max Rosett sold $1.1M of Immunome (IMNM)
Executed Jun 15, disclosed Jun 17, 2 days later.
Value, as filed
$1.1M
60,000 sh × $18.23
Executed
Jun 15
the trade date, as filed
Disclosed
Jun 17
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MRMax Rosett (Chief Financial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Immunome, Inc. (IMNM). The largest single filing was $1.4M of IMNM (63,656 sh × $21.91, as filed), executed Apr 2.
The name
IMNMHealthcare · Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-dr…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Max Rosett in IMNM
IMNMSALE
Immunome, Inc.
$1.4M63,656 sh × $21.91
Exec Apr 2
Filed Apr 3 · 5:30 PM ET IMNMSALE Immunome, Inc. $230K
14,380 sh × $16.01
Exec Sep 19 2024
Filed Sep 20 2024 · 5:30 PM ET